How Long Does Kratom Stay in Urine?

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: Most people clear Kratom from urine within ~3 days of last use — heavy or daily use stretches that window substantially. Specialized LC–MS tests for mitragynine exist (labs vary, often 1–100 ng/mL); not on any standard immunoassay panel.

Kratom detection windows by test type

Each specimen tells a different story because each samples different biology:

Ranges reflect occasional-to-heavy use patterns from FDA device inserts and SAMHSA-certified lab conventions.
Test typeTypical Kratom detection window
Urineoccasional: ~3 days · regular: 5–7 days · heavy: up to ~9 days documented in chronic users
Saliva (Mouth Swab)any: ~1–3 days (specialized)
Hair Folliclesup to 90 days (rarely offered)
Bloodany: ~2–3 days

('Urine remains the employment default because it balances cost, window-length and legal defensibility. Metabolite CONCENTRATIONS (not presence/absence) decide results against cutoff tables, which is why hydration status moves numbers and why validity checks (creatinine, specific gravity) police dilution attempts.',)

Why detection works this way

Kratom is not on standard workplace panels. Its active alkaloids bind opioid receptors but are structurally unrelated to morphine, so opiate immunoassays do not react — a kratom user screens negative on a normal 5/10/12-panel cup.

Specialized liquid-chromatography testing can identify mitragynine and 7-hydroxymitragynine, but those tests are ordered mainly by pain clinics, researchers, or coroners, not HR departments.

Some 'legal high' warning systems now test for 7-OH specifically as concentrated extracts grow. If your program tests for novel psychoactive compounds, ask which expanded list applies.

Factors that stretch or shrink your window

  • Frequency & dose — chronic use saturates stores; single use clears fastest.
  • Body composition — some metabolites persist longer with higher body-fat percentages.
  • Metabolism & hydration — concentration shifts with fluid intake; elimination speed does not.
  • Potency & route — concentrates and edibles deliver more analyte than light use.

Testing cutoffs in plain language

Specialized LC–MS tests for mitragynine exist (labs vary, often 1–100 ng/mL); not on any standard immunoassay panel. A specimen under the initial cutoff reports negative without further work; a screen above cutoff gets confirmed by mass spectrometry before anyone sees a positive.

Planning ahead? Our at-home drug test guide covers retail kits that mirror lab screens.

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Does Kratom Show up on a Drug Test?

No — Kratom is absent from standard drug panels. Full guide →

Will Kratom Make You Fail a Drug Test?

Can Kratom trigger a false positive? Cross-reactivity evidence, confirmation testing, and how to clear your name with the MRO. Full guide →

How Long Can Kratom Be Detected in a Drug Test?

How long Kratom stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →

How to Pass a Drug Test for Kratom?

Evidence-based ways to pass a drug test for Kratom — realistic timelines, what works, what backfires, and dilution flags to avoid. Full guide →

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)